Topical lithium succinate ointment (Efalith) in the treatment of AIDS- related seborrhoeic dermatitis

Clinical and Experimental Dermatology

Volumn 22, Issue 5, 1997, Pages 216-219

  Langtry, J A A ^a,c   Rowland Payne, C M E ^a   Staughton, R C D ^a   Stewart, J C M ^b   Horrobin, D F ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Scotia Pharmaceuticals   (United Kingdom)

^c SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUCCINATE LITHIUM;

AIDS RELATED COMPLEX; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; OINTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SEBORRHEIC DERMATITIS; TOPICAL DRUG ADMINISTRATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; HUMANS; LITHIUM COMPOUNDS; MALE; OINTMENTS; TREATMENT OUTCOME;

EID: 6844260534     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1997.tb01071.x     Document Type: Article

References (32)

1. Ive FA, Rowland Payne CME. Seborrhoeic dermatitis. In: Verbov J ed. Superficial Fungal Infections, New Clinical Applications. Dermatology series. MTP Press Ltd. 1986: 73-87.
2. Farthing CF, Staughton RCD, Rowland Payne CME. Skin disease in homosexual patients with acquired immune deficiency syndrome (AIDS) and lesser forms of human T-cell leukaemia virus (HTLV-III) disease. Clin Exp Dermatol 1985; 10: 3-12.
3. Farthing CF, Brown SE, Staughton RCD. A Colour Atlas of AIDS and HIV Disease, 2nd edn. London: Wolfe, 1988.
4. Senaldi G, Di Perri G, Di Silverio A, Minoli L. Seborrhoeic dermatitis; an early manifestation in AIDS. Clin Exp Dermatol 1987; 12: 72-3.
5. Smith KJ, Skelton HG, Yeager J, Ledsky R et al. Cutaneous findings in HIV-1-positive patients: a 42 month prospective study. J. Am Acad Dermatol 1994; 31: 746-54.
6. Efalith Multicenter Trial Group. A double-blind, placebo-controlled multi-center trial of lithium succinate ointment in the treatment of seborrhoeic dermatitis. J Am Acad Dermatol 1992; 26: 452-7.
7. Statgraphics (Version 5). 1991. Statistical Graphics Corporation, Maryland 20852, USA.
8. Faergemann J. Pityrosporum ovale and skin diseases. Keio J Med 1993; 42: 91-4.
9. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare; treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort). Br J Dermatol 1986; 114: 695-700.
10. Groisser D, Bottone EJ, Lebwohl M. Association of Pityrosporum orbiculare (Malassezia furfur) with seborrhoeic dermatitis in patients with acquired immuno-deficiency syndrome (AIDS). J Am Acad Dermatol 1989; 20: 770-3.
11. McGrath J, Murphy GM. The control of seborrhoeic dermatitis and dandruff by anti-pityrosporal drugs. Drugs 1991; 41: 178-84.
12. Abood JK, Lösel DM, Ayres PG. Changes in abundance and infectivity of powdery mildew conidia from cucumber plants treated systemically with lithium chloride. Plant Pathology 1992; 41: 255-61.
13. Leeming JP, Burton JL. Lithium succinate and seborrhoeic dermatitis, an anti-fungal mode of action? Br J Dermatol 1990; 122: 718-9.
14. Nenoff R, Haustein UF, Münzberger C. In vitro activity of lithium succinate against Malassezia furfur. Dermatology 1995; 190: 48-50.
15. Wilde PF, Stewart PS. A Study of the fatty acid metabolism of the yeast Pityrospnrum male. Biochem J 1968; 108: 225-31.
16. Horrobin DF. Effects of lithium on essential fatty acid and prostaglandin metabolism. In: Bach RO, Gallichio VS ed. Lithium and Cell Physiology. New York: Springer Verlag 1990: 137-49.
17. El Mallakh RS. Lithium. Conn Med 1990; 54: 115-26.
18. Wilson R, Fraser WD, McKillop JH, Smith J et al. The in-vitro effects of lithium on the immune system. Autoimmunity 1989; 4: 119-24.
19. Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W. Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression. Cytokine 1991; 3: 284-91.
20. Wu Y, Yang GX. Enhancement of interleukin 2 production in human and Gibbon T cells after in-vitro treatment with lithium. Proc Soc Exp Biol Med 1991; 198: 620-4.
21. Sztein MB, Simon GL, Parenti DM et al. In-vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIY seropositive male homosexuals with AIDS-related complex. Clin Immunol Immunopath 1987; 44: 51-62.
22. Bloomfield FJ, Young MM. Influence of lithium and fluoride on degranulation from human neurophils in-vitro. Inflammation 1982; 3: 257-67.
23. Parenti DM, Simon GL, Scheib RG, Meyer III WA et al. Effect of lithium carbonate in HIY infected patients with immune dysfunction. J Acquir Immune Defic Syndr 1988; 1: 119-24.
24. Barrios NJ, Betancourt D, Paulos A, Kirkpatrick DV. Response to high dose steroids, immunogloblin and lithium in HIV-1 infection and bone marrow aplasia. A case report. Lithium 1991; 2: 72-4.
25. Roberts DE, Berman SM, Nakasato S, Wyle FA et al. Effect of lithium carbonate on zidovudine-associated neutropenia in the acquired immuno-deficiency syndrome. Am J Med 1988; 85: 428-31.
26. Sampson B, Curtis JR, Stewart JCM, Cream JJ. Lithium succinate ointment in uremic pruritus. Trace Elements in Medicine 1992; 9: 7-8.
27. Bakken IJ, Vincent MB, White LR, Cappelen J et al. Low concentrations of lithium and cyclooxygenase inhibitors enhance endothelin-1 (ET-1)-induced contractions in human temporal artery, but not in porcine opthalmic artery. Headache 1992; 32: 475-9.
28. Jankovic BD, Popeskovic L, Isakokovic K. Cation-induced immuno-suppression; the effect of lithium on Arthus reactivity, delayed hypersensitivity and antibody production in the rat. Adv Exp Med Biol 1979; 114: 339-44.
29. Alexandrov PN, Speranskaia TV. Dynamics of carrageenin-induced inflammation after use of lithium oxybutyrate. Biull Eksp Biol Med 1988; 106: 233-5.
30. O'Riordan JW, Kelleher D, Williams Y, Bloomfield FJ. Effect of lithium therapy on inflammatory response. Inflammation 1986; 10: 49-57.
31. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341: 197-205.
32. Cooke JE. Drug interactions in anesthesia. Clin Plast Surg 1985; 12: 83-9.